THIS PROFILE IS FROM 2006, AND CONTAINS INFORMATION THAT MAY NO LONGER BE CURRENT.
#7 MedImmune
1 Medimmune Way
Gaithersburg, MD 20878
Tel: (877) 633-4411
Fax: (301) 398-9000
www.medimmune.com
Headcount |
2,215 |
|
Year Established |
1988 |
|
Biopharma Revenues |
$1,221 |
+9% |
Total Revenues |
$1,244 |
+9% |
Royalty Revenues |
$23 |
+35% |
Net Loss |
-$17 |
n/a |
R&D Budget |
$385 |
+18% |
Drugs Pending Approval
|
Drug |
Indication |
medi-545 |
lupus |
caiv-t |
refrigerator-stable formulation of FluMist |
Drugs in Phase IIb and Beyond |
Drug |
Indication |
numax Mab |
lower respiratory tract disease from RSV |
epstein-barr vaccine |
Epstein-Barr virus |
abegrin |
prostate cancer, melanoma |
HPV vaccine |
cervical cancer from HPV |
ethyol |
mucositis |
Early Research Projects
|
Drug |
Indication |
rsv vaccine |
respiratory syncytial virus |
vaccine programs |
hMPV and PIV-3 |
mt-103 |
B-cell lymphoma and leukemia |
ephA2 |
oncology |
ephA4 |
pancreatic cancer |
hMGB-1 |
rheumatoid arthritis |
siplizumab |
T-cell lymphoma |
Top Selling Drugs |
Drug |
Indication |
Sales |
(+/-%) |
synagis |
respiratory syncytial virus |
$1,063 |
+13% |
ethyol |
renal toxicity from chemotherapy |
$95 |
+3% |
flumist |
influenza |
$21 |
-56% |
Account for 97% of total biopharma sales, up from 96% in 2004.
Previous Profile: Genzyme // Next Profile: Chiron
Top 10 Biopharma Report homepage